CORRESPONDENCE studies can be combined for meta-analysis, enabling researchers to home in on the true effect.
no other statistic fills this particular niche. Moreover, the alternatives (such as estimates, confidence intervals, false discovery rates, etc.) are also subject to random variation and, like P values, can behave badly if experiments are poorly designed or implemented. Nonetheless, we do not suggest that researchers rely on P values alone. Parameter estimates and confidence intervals, in particular, can describe data in a more detailed, contextual way. The P value gained its unique prominence because it is simple and interpretable across a variety of settings, despite the fact that it is sometimes misunderstood. P values are variable, but this variability reflects the real uncertainty inherent in statistical results. Thus, we believe P values will continue to have an important role in research, but an explicit understanding of P-value uncertainty can improve their interpretation. However, in practice, simply providing tools for quantifying the fickleness of P will highlight an endemic problem without offering any treatment. Whereas Lazzeroni et al. suggest providing information to support P, we have suggested using measures that supersede P for interpreting data 3,4 . Effect sizes can be standardized, are not based on dichotomous decision making (the flaws of which severely limit the value of statistical power 5 ) and address the more natural research question of how big the effect is, rather than simply asking whether there is an effect 3, 6 . And 95% confidence intervals for the effect size provide a more consistent indication of the true (population-level) condition than does P. Thus comparing the effect sizes and confidence intervals of several similar studies typically uncovers a coherent pattern that is masked when only the P values of those studies are compared 2 . Furthermore, and crucially, the sample effect sizes and confidence limits of multiple
Estimation statistics should replace significance testing
To the Editor: For more than 40 years, null-hypothesis significance testing and P values have been questioned by statistical commentators, their utility criticized on philosophical and practical grounds 1 . Luckily, the preferred statistical methodology is accessible with modest retraining. An obstacle to the adoption of this alternative seems to be the lack of a widely used name; we suggest the term 'estimation statistics' to describe the group of methods that focus on the estimation of effect sizes (point estimates) and their confidence intervals (precision estimates). Estimation statistics offers several key benefits with respect to current methods.
Estimation is an informative way to analyze and interpret data. For example, for an experiment with two independent groups, the estimation counterpart to a t-test is calculation of the mean difference (MD) and its confidence interval 2 . One calculates the MD by subtracting the mean for one group from the mean for the other, and its confidence interval falls between MD -(1.96 × SEMD) and MD + (1.96 × SEMD), where SEMD is the pooled standard error of the MD 3 . For quantitative science, it is more useful to know and think about the magnitude and precision of an effect than it is to contemplate the probability of observing data of at least that extremity, assuming absolutely no effect. An old joke about studynpg ing metal springs: estimation reveals the proportionality between force and extension, Hooke's law; P tells you, "When you pull on it, it gets longer" 4 . Medical research has led the way in adopting estimation statistics. Using the effect size in the clinical research context rightfully places the focus on the magnitude of a treatment's benefit, a perspective that has greatly advanced clinical decision making. For basic research, adopting effect sizes would better facilitate quantitative comparisons and models (such as Hooke's law). Importantly, thinking about effect sizes during data interpretation encourages an analyst to have greater awareness of the metrics being used and how they relate to the natural processes under study.
The second key benefit of estimation statistics is that it allows for the synthesis of data from published sources by means of systematic literature review and meta-analysis. Meta-analysis is a way to average effect sizes from different studies, which produces a more precise overall estimate (that is, a narrower confidence interval). In medical research, meta-analytic studies of randomized controlled clinical trials are considered the strongest form of medical evidence; they are used to reconcile discordant results, produce precise estimates of treatment effects, identify knowledge gaps, guide clinical practice and inform further investigation. Meta-analyses are published in numerous medical journals as a quantitative alternative to the conventional 'he said/she said' narrative review. Meta-analytic studies are now also being used in preclinical research; for example, a recent study showed that the animal-model literature on stroke overstates efficacy 5 .
Estimation statistics' third important benefit is its use of model construction to quantify trends in heterogeneous primary or published data. Models can be basic or more advanced, such as multivariate meta-regression, a method that accounts for sources of experimental heterogeneity in complex data. Like clinical data, basic research results are well suited to the use of multivariate models to analyze both primary and pooled published data from complex experimental designs. When the data have high integrity, such models can resolve discordance and misinterpretation caused by significance tests 6 .
The use of estimation statistics remains rare in basic research. We suggest that as researchers become increasingly aware of the limitations of significance testing, they should use estimation in its place.
